The “Alpine Winter Conference on Medicinal and Synthetic Chemistry” exposes attending scientists to cutting edge synthetic and medicinal chemistry as well as developments in technologies that foster innovation in drug discovery. The main target audience will include medicinal and synthetic chemists, as well as related drug discovery disciplines from both industry and academia as well as graduate/undergraduate students and postdocs.
|The discovery of DNDI6510 as orally bioavailable SARS-COV2 MPro inhibitor
Griffen E*, COVID Moonshot Consortium**
**including Sjö P